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     Serotonin exerts an inhibitory effect on food intakes. D-Lys3 -GHRP-6 is a ghrelin receptor antagonist 
which inhibits fasting or ghrelin- induced food intake. In the present study, the effects of serotonin on food 
intakes were investigated in D-Lys
3
- GHRP-6- treated food-deprived male rats. Twenty food-deprived male 
rats in four groups (5 in each) received third cerebral ventricular injection of saline, 10µg serotonin, 20nmol 
D-Lys
3
 -GHRP-6 or combination of D-Lys
3
-GHRP-6 and serotonin respectively.  Mean of one hour food 
intakes were measured. Data was analyzed by one-way analysis of variance (ANOVA) with post hoc 
Tukey’s test.  In all cases, P<0.05 was considered to be statistically significant. Serotonin, D-Lys
3
- GHRP-6 
or combination of serotonin/D-Lys
3
- GHRP-6 decreased the mean food intakes significantly when compared 
to saline. A significant decrease was observed on mean food intakes between combination of D-Lys
3
-GHRP-
6 and serotonin group and serotonin or D-Lys
3
- GHRP-6 groups. A significant decrease was not observed on 
food intakes between serotonin and D-Lys
3
- GHRP-6 groups. Serotonin and D-Lys
3
-GHRP-6 may exert 
synergistic inhibitory effects on food intake in rats. Decrease of the ghrelin pathway activity may have a role 
in mediating the inhibitory effects of serotonin on food intakes. 
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INTRODUCTION 
     The hypothalamus is a key regulator of feeding 
behavior. Co-localization of anorexigenic and 
orexigenic neuronal projections highlights the 
hypothalamus as a key regulatory site of energy 
balance and metabolism [1]. Ghrelin is a 28 
amino acid peptide which it mainly synthesized 
by the stomach and hypothalamus nuclei. It acts 
as endogen ligand for growth hormone 
secretagogues receptor (GHSR-Ia) and increases 
food intakes and body weight via GHSR-Ia [2]. 
D-Lys
3
 -GHRP-6 is a synthetic peptide which acts 
as a GHSR-Ia receptor antagonist [3-4]; it has 
been shown that central or peripheral injection of 
it inhibits gastric emptying, food intakes and body 
weight in food-deprived or ghrelin treated mice or 
rats [5-6]. 
Serotonin (5-hydroxytryptamine [5-HT]) is a 
monoamine neurotransmitter which is synthesized 
from the essential amino acid tryptophan by the 
action of hydroxylase and decarboxylase enzymes 
[7]. Hypothalamus receives the fibers of 
serotonergic neurons of raphe nuclei [8].  It has 
been shown that central or peripheral injections of 
serotonin or serotonergic drugs exert inhibitory 
effects on food intakes via 5HT2C and 5HT1B 
receptors [9-13]. The injections of 5HT2C and 
5HT1B receptors antagonists increase food 
intakes [11]. Based on these studies, 
hypothalamic interneurons may play an important 
role in mediating the effects of serotonin on food 
intakes. The present study is aimed at 
investigating the effects of serotonin on food 
intakes in D-Lys
3
- GHRP-6- treated food-
deprived male rats.  
 
MATERIALS AND METHODS 
Animals and drugs 
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     Male Wistar rats weighing 230- 250g 
(provided by the Center of neuroscience Research 
of Shahid Beheshti University, Iran) were housed 
individually in the stainless steel cages under 
controlled temperature (22± 2 C°) and 12:12-h 
light- dark cycle (light on from 0700 to 1900 
daily). Animals had free access to standard 
laboratory food and water all the time except for 
the beginning of the treatments in which rats were 
food-deprived for 24 hours. Experiments were 
executed with the Guide for the Care and Use of 
Laboratory Animals(National Institute of Health 
Publication No. 80-23, revised 1996) and were 
approved by the Research and Ethics Committee 
of Shahid Beheshti University of Medical 
Sciences.  D-Lys
3
- GHRP-6 was purchased from 
Anaspec Company, USA and for the purpose of 
injections, it was dissolved in distilled water. 
Serotonin hydrochloride was purchased from 
Sigma Aldrich, USA; for injection, it was 
dissolved in distilled water. 
Intra cerebral ventricular cannulation 
     For central injections, a 22- gauge stainless 
cannulae was implanted 1mm above the third 
cerebral ventricle according to coordinates of 
Paxinos and Watson Atlas (AP = - 2.3, ML=  0.0, 
DV=7.5). The cannula was secured to the skull 
with three stainless steel screws and dental 
cement [6]. The animals were kept in individual 
cages. After one week recovery period, twenty 
food-deprived rats in four groups (5 in each) 
received saline, 10µg serotonin, 20nmol D-Lys
3
 -
GHRP-6 or combination of D-Lys
3
-GHRP-6 and 
serotonin in a volume of 3µl over one minute 
respectively. The drugs were injected by a 27- 
gauge stainless steel injector (protruded 1mm 
beyond the cannula to reach the third ventricle) 
which was connected to Hamilton micro syringe 
(model 9435, Australia) by PE- 20 tubing via 
third cerebral ventricle. The doses of drugs used  
in the present study were selected on the basis of  
previous studies [5-6]. 
Feeding tests 
     Experiments were started at 9:00. Before 
feeding tests, rats were food-deprived for 24 
hours with free access to water. Food intake was 
measured by subtracting uneaten food from the 
initially premeasured food at one hour after 
injections (5-6). 
Statistical analysis 
      All data were expressed as mean± SEM. Data 
was analyzed by one- way analysis of variance 
ANOVA with post hoc Tukey’s test.  All 
statistical analyses were performed with SPSS 
16.0 software and the figures were drawn by 
Microsoft office excel 2007. In all cases, P<0.05 
was considered to be statistically significant. 
 
RESULTS 
     By the injections of serotonin, D- Lys
3
- 
GHRP-6 or combination of serotonin and D-Lys
3
-
GHRP-6 decreased the mean significantly with 
one hour food intake in food-deprived rats 
compared to food-deprived saline- treated group 
(P<0.05)(Fig1). Also a significant decrease was 
observed in food intake in combination of D-
Lys
3
-GHRP-6 and serotonin group compared to 
serotonin alone or D- Lys
3
- GHRP-6 alone group 
(P<0.05) (Fig1). No significant decrease was 
observed between food-deprived serotonin treated 






























Figure 1 The effects of serotonin (10µg), D- Lys3- GHRP-6 (20 nmol) or combination of D-Lys3-GHRP-6 and serotonin on mean of 




     The results showed that ICV injection of 
serotonin decreased food intakes in rats 
significantly when compared to food-deprived 
saline treated ones. This result is consistent with 
the previous studies which reported that serotonin 
or serotonergic drugs exerts anorexigenic effect 
on food intakes in fed or food-deprived rats [9-
13]. Previous studies have established that ghrelin 
is synthesized during fasting and play an 
important role in the regulation of the food intake 
[2]. Central injection of ghrelin to fed rats or 24 
hour food deprivation resulted in a similar 
increase in circulating ghrelin concentration and 
similar increase in daily food intake [2]. It was 
also demonstrated that GHSR-Ia receptor is one 
of the most important receptors involved in 
mediating the effects of fasting or ghrelin on food 
intakes [2-5]; the antagonists of this receptor may 
play a role in the obesity treatment. The results of 
the present study showed that injections of D-
Lys
3
- GHRP-6 decreased the food intakes in rats 
significantly when compared to food-deprived 
saline treated ones. This result is consistent with 
the study which reported that D-Lys
3
- GHRP-6 
exerts anorexigenic effect on food intake in 16 
hours food-deprived or fed-ghrelin treated male 
mice [5]. Moreover, these results are consistent 
with our previous laboratory results which 
demonstrated that central injection of D-Lys
3
- 
GHRP-6 decreases food intakes and NPY gene 
expression in food-deprived male rats [6]. 
This study aimed to investigate the interaction of 
serotonergic and ghrelin pathway on food intake  
in 24 hour food-deprived rats for the first time. 
The results showed that the combined injection of 
D-Lys
3
- GHRP-6 and serotonin decreases food 
intakes significantly when compared to only 
serotonin or D-Lys
3
- GHRP-6 groups. It is clearly 
shown that ghrelin injection or food deprivation 
exerts their stimulatory effects on food intakes via 
increasing NPY/AgRP and decreasing α-
MSH/CARP neurons activity [2, 10, 14]. Also, 
our previous study did not report any significant 
difference on the NPY gene expression level 
between food-deprived or ghrelin treated rats [2]. 
This study also showed that NPY/AgRP and α-
MSH/CARP play an important role in mediating 
the inhibitory effects of serotonergic pathway on  
food intakes and loss of body weight [2, 10, 14]. 
Recent studies have established that serotonergic 
drugs including fenfluxamine decrease plasma 
ghrelin concentrations and they inhibit gastric 
emptying [15-16]. Based on previous information 
and the results of the present study, ghrelin 
pathway may have a role in mediating serotonin 
effects on food intake and serotonin may exert 
inhibitory effects on appetite partly by decreasing 
the ghrelin secretion and following decrease of 
NPY/ AgRP gene expression. 
 
CONCLUSION 
     The results showed that serotonin and D-Lys
3
-
GHRP-6 exert synergistic inhibitory effects on 
food intakes in 24 hours food-deprived rats. 
Decrease of the ghrelin pathway activity may 
have a role in mediating the inhibitory effects of 
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